|

Post Marketing Study on Pluvicto in Korea

RECRUITINGSponsored by Novartis Pharmaceuticals
Actively Recruiting
SponsorNovartis Pharmaceuticals
Started2025-04-18
Est. completion2028-05-31
Eligibility
Age18 Years – 100 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06514521

Summary

Post marketing study on Pluvicto in Korea

Eligibility

Age: 18 Years – 100 YearsSex: MALEHealthy volunteers accepted
Inclusion criteria

Study participants eligible for inclusion in this study must meet all of the following criteria:

1. Male adult patient age ≥ 18
2. Subject who are being treated with Pluvicto or whose treatment plan is finalized and scheduled to be administered at the time of consent by physician in accordance with the approved indication in South Korea
3. Subject who provided the written informed consent prior to the study enrollment

Exclusion criteria

Study participants meeting any of the following criteria are not eligible for inclusion in this study:

1. Subject whose medical record is not accessible
2. Subject who is not willing to provide the informed consent

Conditions2

CancerMetastatic Castration-resistant Prostate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.